Cargando…
The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society of Cardiology
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378023/ https://www.ncbi.nlm.nih.gov/pubmed/28382072 http://dx.doi.org/10.4070/kcj.2017.0011 |
| _version_ | 1782519392351813632 |
|---|---|
| author | Han, Ji Whan |
| author_facet | Han, Ji Whan |
| author_sort | Han, Ji Whan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5378023 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | The Korean Society of Cardiology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-53780232017-04-05 The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease? Han, Ji Whan Korean Circ J Editorial The Korean Society of Cardiology 2017-03 2017-03-08 /pmc/articles/PMC5378023/ /pubmed/28382072 http://dx.doi.org/10.4070/kcj.2017.0011 Text en Copyright © 2017 The Korean Society of Cardiology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Han, Ji Whan The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease? |
| title | The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease? |
| title_full | The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease? |
| title_fullStr | The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease? |
| title_full_unstemmed | The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease? |
| title_short | The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease? |
| title_sort | efficacy and safety of high-dose intravenous immunoglobulin in the treatment of kawasaki disease: how can we predict resistance to intravenous immunoglobulin treatment of kawasaki disease? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378023/ https://www.ncbi.nlm.nih.gov/pubmed/28382072 http://dx.doi.org/10.4070/kcj.2017.0011 |
| work_keys_str_mv | AT hanjiwhan theefficacyandsafetyofhighdoseintravenousimmunoglobulininthetreatmentofkawasakidiseasehowcanwepredictresistancetointravenousimmunoglobulintreatmentofkawasakidisease AT hanjiwhan efficacyandsafetyofhighdoseintravenousimmunoglobulininthetreatmentofkawasakidiseasehowcanwepredictresistancetointravenousimmunoglobulintreatmentofkawasakidisease |